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Infection Control Precautions for Aerosol-Generating Procedures on 
Patients who have Suspected Severe Acute Respiratory Syndrome (SARS)
Multiple cases of suspected Severe Acute Respiratory Syndrome (SARS) have occurred in healthcare personnel who had 
cared for other patients with SARS. During the course of the investigation, CDC has received anecdotal reports that aerosol­
generating procedures may have facilitated transmission of the etiologic agent of SARS in some cases. Procedures that 
induce coughing can increase the likelihood of droplet nuclei being expelled into the air. These potentially aerosol-generating 
procedures include aerosolized medication treatments (e.g., albuterol), diagnostic sputum induction, bronchoscopy, airway 
suctioning, and endotracheal intubation. For this reason, healthcare personnel should ensure that patients have been 
evaluated for SARS before initiation of aerosol-generating procedures. Evaluation for SARS should be based on the most 
recent case definition for SARS (http://www.cdc.gov/ncidod/sars/casedefin ition.htm ). Aerosol-inducing procedures should 
be performed on patients who may have SARS only when such procedures are deemed medically necessary. These 
procedures should be performed using airborne precautions as previously described for other infectious agents, such as 
Mycobacterium tuberculosis; Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care 
Facilities (http://www.cdc.gov/m m wr/preview/m m wrhtm l/00035909.htm ). In summary, healthcare personnel should 
apply standard, (e.g., hand hygiene), airborne (e.g., respiratory protective devices with a filter efficiency of greater than or 
equal to 95%), and contact (e.g., gloves, gown, and eyewear) precautions when aerosol-generating procedures are being 
performed on patients who may have SARS.
Other information on appropriate infection control precautions for patients with suspected SARS can be found at 
http://www.cdc.gov/ncidod/sars/infectioncontrol.htm .
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